Remdesivir Demonstrates Further Promise

June 18, 2020

Remdesivir Demonstrates Further Promise

Gilead Science’s antiviral COVID treatment, remdesivir, effectively prevents lung damage in macaque monkeys infected with coronavirus, according to findings published in Nature. Yourway offers direct-to-patient services to help trials continue to run and provide convenience for patients when they can’t leave their homes.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply Europe

February 24-26, 2026
Hyatt Regency, Barcelona Tower

Schedule a Meeting

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Schedule a Meeting

Media

Articles

Why Integration Matters in Clinical Supply Chains

Open chat

Hello! How can I help you?